Johnson & Johnson’s Ethicon Ordered to Pay $76.6 Million in AI Imaging Dispute

In a recent ruling, a New York federal judge determined that Johnson & Johnson’s Ethicon unit is required to pay ChemImage Corp. $76.6 million. This resolution follows the unilateral termination of a collaboration aimed at developing artificial intelligence imaging techniques for use during surgery. The court’s decision involved accepting ChemImage’s proposed 17% discount rate on intellectual property impairment damages, contrasted with Ethicon’s suggested 40% rate. For further details on this case, visit the report by Law360.